|
Children's Tumor Foundation visits the NYSE. In honor of the occasion, John Risner, President, and George Orfanakos, Executive Director of the Children’s Tumor Foundation, ring The Opening BellSM.
Click the link below to view an archived webcast of The Opening Bell.
 Windows Media Player 300k
About Children's Tumor Foundation:
Children’s Tumor Foundation was founded to be an advocate and fundraiser to end Neurofibromatosis (NF) through research. NF is the term for three distinct genetic disorders, NF1, NF2 and Schwannomatosis. The most common form, NF1 (1-3,000 births), has a wide range of severity, varying from café au lait spots to learning disabilities, bone abnormalities, and brain and spinal tumors. NF2 (1-25,000 births) is characterized by multiple brain and spinal tumors, commonly causing deafness, severe balance problems, decreased mobility and vision loss. Schwannomatosis (1-40,000 births) causes nerve tumors associated with chronic pain. NF affects both sexes and all races and ethnic groups equally. NF is more prevalent than cystic fibrosis, Duchenne muscular dystrophy and Huntington’s disease combined.
|
